arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Chemed Corp.

CHE Health Care Medical/Nursing Services
$519.84
▼ -0.1% Today
as of Sep 4, 16:47 ET
Last 30 days +0.43% Jul 28 → Sep 04
$512.17 $523.06 $533.94 $544.83 $555.72 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$519.62
High
$524.95
Low
$519.31
Volume
$84,272
Avg Vol
$200,092
Mkt Cap
$7.2B
P/E (TTM)
36.02
Beta
—
52w High
$557.00
52w Low
$365.21
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 21 items

Sep 6 · 01:15 Motley Fool
Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040
Aug 27 · 15:30 Zacks
Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
Aug 25 · 15:40 Zacks
OPCH or CHE: Which Is the Better Value Stock Right Now?
▸ Show all 21 press releases & news Free account →

Overview

52-week range
$365
$557
81% of range
Avg surprise (last 2)
-6.9%
Avg reaction (last 1)
+1.0%
100% positive
Latest IV / EM
27%
EM ±4.2% · $520 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$3.51$3.93$4.35$4.77$5.19 Actual $3.58Actual $3.51Actual $4.93Actual $4.24Actual $4.65Actual $5.00Actual $5.11Est $5.19Actual $3.75Est $4.27Actual $4.46Actual $4.84Actual $5.13 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$177M$353M$530M$707M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $5.13 — — — — financials
Tue Mar 31, 2026Mar 2026 $4.84 — — — — financials
Tue Sep 30, 2025Sep 2025 $4.46 — — — — financials
Tue Jul 29, 2025Jun/2025 $3.75 $4.27 -12.2% — — earnings
Wed Apr 23, 2025Mar/2025 $5.11 $5.19 -1.5% — +1.0% earnings
Mon Sep 30, 2024Sep 2024 $5.00 — — — — financials
Sun Jun 30, 2024Jun 2024 $4.65 — — — — financials
Sun Mar 31, 2024Mar 2024 $4.24 — — — — financials
Sat Sep 30, 2023Sep 2023 $4.93 — — — — financials
Fri Jun 30, 2023Jun 2023 $3.51 — — — — financials
Fri Mar 31, 2023Mar 2023 $3.58 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$673M$658M—$625M$619M$647M—$606M
Cost of revenue$452M$442M—$428M$434M$431M—$396M
Gross profit————————
Operating income$89M$85M—$75M$68M$95M—$92M
Net income$68M$66M—$64M$52M$72M—$76M
EPS (diluted)$5.13$4.84—$4.46$3.57$4.86—$5.00

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$40M$17M$75M$130M$250M$174M$178M$238M
Inventory$8M$7M$8M$8M$9M$8M$8M$10M
Total current assets$291M$274M$303M$395M$491M$502M$395M$490M
Total assets$1.58B$1.54B$1.54B$1.62B$1.72B$1.73B$1.67B$1.77B
Long-term debt$140M$91M——————
Total liabilities$749M$688M$559M$547M$519M$545M$550M$534M
Total equity$831M$848M$979M$1.08B$1.20B$1.18B$1.12B$1.24B

Implied volatility — last 90 days

17%28%39%50%61% Jun 07 — IV 31% · EM ±4.2%Jun 08 — IV 27% · EM ±3.5%Jun 09 — IV 28% · EM ±3.5%Jun 10 — IV 44% · EM ±5.2%Jun 11 — IV 38% · EM ±4.2%Jun 12 — IV 43% · EM ±4.4%Jun 15 — IV 48% · EM ±3.5%Jun 16 — IV 44% · EM ±2.6%Jun 17 — IV 61% · EM ±2.6%Jun 19 — IV 29% · EM ±6.3%Jun 22 — IV 28% · EM ±5.8%Jun 23 — IV 28% · EM ±5.8%Jun 24 — IV 26% · EM ±5.2%Jun 25 — IV 26% · EM ±5.1%Jun 26 — IV 25% · EM ±4.7%Jun 29 — IV 26% · EM ±4.6%Jun 30 — IV 26% · EM ±4.4%Jul 01 — IV 24% · EM ±3.9%Jul 02 — IV 23% · EM ±3.7%Jul 03 — IV 24% · EM ±3.7%Jul 06 — IV 28% · EM ±3.9%Jul 07 — IV 27% · EM ±3.5%Jul 08 — IV 28% · EM ±3.5%Jul 09 — IV 26% · EM ±3.1%Jul 10 — IV 23% · EM ±2.5%Jul 13 — IV 31% · EM ±2.5%Jul 14 — IV 32% · EM ±2.3%Jul 15 — IV 36% · EM ±2.1%Jul 16 — IV 37% · EM ±1.6%Jul 20 — IV 36% · EM ±8.5%Jul 21 — IV 38% · EM ±8.8%Jul 22 — IV 37% · EM ±8.5%Jul 23 — IV 37% · EM ±8.4%Jul 24 — IV 37% · EM ±8.3%Jul 27 — IV 45% · EM ±9.3%Jul 28 — IV 43% · EM ±8.8%Jul 29 — IV 26% · EM ±5.1%Jul 30 — IV 25% · EM ±4.9%Jul 31 — IV 26% · EM ±4.9%Aug 03 — IV 25% · EM ±4.5%Aug 04 — IV 25% · EM ±4.3%Aug 05 — IV 19% · EM ±3.2%Aug 06 — IV 21% · EM ±3.5%Aug 07 — IV 23% · EM ±3.5%Aug 10 — IV 17% · EM ±2.4%Aug 11 — IV 23% · EM ±3.0%Aug 12 — IV 20% · EM ±2.5%Aug 13 — IV 33% · EM ±3.9%Aug 14 — IV 33% · EM ±3.7%Aug 17 — IV 39% · EM ±3.3%Aug 18 — IV 45% · EM ±3.2%Aug 19 — IV 33% · EM ±2.0%Aug 20 — IV 60% · EM ±2.5%Aug 24 — IV 30% · EM ±6.2%Aug 25 — IV 30% · EM ±6.1%Aug 26 — IV 26% · EM ±5.2%Aug 27 — IV 30% · EM ±5.9%Aug 28 — IV 27% · EM ±5.2%Aug 31 — IV 27% · EM ±4.7%Sep 01 — IV 28% · EM ±4.8%Sep 02 — IV 28% · EM ±4.7%Sep 03 — IV 27% · EM ±4.4%Sep 04 — IV 27% · EM ±4.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in